fda green list glp-1 What's New in Obesity Treatment? GLP-1 Pipeline Update: May 2026

As of the date of this publication, Novi has not been publicly named in FDA warning letters

We dont really know yet

While various studies have examined the effects of GLP-1 agonists in obesity, two notable phase 3 trials are worth highlighting in this context

Resistance training provides the strongest signal for the body to maintain muscle during weight loss

In addition, this formula provides 1 Billion CFU of Lactobacillus acidophilus, a probiotic known for promoting digestive regularity and supporting immune function

How GLP1 medications change your relationship with alcohol GLP1 receptor agonists slow gastric emptying, reduce appetite, and act on reward pathways in the brain